Parameters | Events/patients | Uni-variate analysis | Multivariate analysis | |
---|---|---|---|---|
 |  | P value | HR (95% CI) | P value |
Age | Â | Â | Â | Â |
<61 | 18/142 | Â | Â | Â |
61-70 | 15/153 | 0.302 | _ | _ |
>70 | 9/138 | Â | Â | Â |
Sex | Â | Â | Â | Â |
Male | 41/413 | 0.445 | _ | _ |
Female | 1/20 | Â | Â | Â |
Sub-stage | Â | Â | Â | Â |
T1A | 28/324 | 0.24 | _ | _ |
T1B | 14/109 | Â | Â | Â |
Grade | Â | Â | Â | Â |
Well diff | 9/154 | Â | 1 | Â |
Mod diff | 29/273 | 0.0001* | 1.91 (1.2-3.85) | 0.035* |
Poorly diff | 4/6 | Â | 7.5 (3.42-15.24) | Â |
Hb | Â | Â | Â | Â |
< 13.0 | 6/45 | 0.367 | _ | _ |
≥ 13.0 | 36/388 |  |  |  |
AC | Â | Â | Â | Â |
No | 14/236 | 0.004* | 1 | 0.011* |
Yes | 28/197 | Â | 2.34 (1.21-4.52) | Â |
Field size (cm2) | Â | Â | Â | Â |
<30.5 | 35/215 | Â | Â | Â |
30.5-35.5 | 7/165 | 0.534 | _ | _ |
> 35.5 | 0/53 | Â | Â | Â |
Dose size | Â | Â | Â | Â |
2.0 Gy | 32/256 | 0.021* | 2.17 (1.28-4.18) | 0.035* |
2.5 Gy | 10/177 | Â | 1 | Â |
Tumor BED | Â | Â | Â | Â |
< 65 (Gy15) | 29/239 | 0.025* | 3.38 (1.29-7.83) | 0.017* |
≥ 65 (Gy15) | 13/194 |  | 1 |  |
Tx period | Â | Â | Â | Â |
1983-1990 | 10/115 | Â | Â | Â |
1991-2000 | 25/224 | 0.643 | _ | _ |
2001-2005 | 7/94 | Â | Â | Â |